Conversations on Today's Priorities
Hear from the top thought-leaders on global, interdisciplinary topics about the future of therapeutics, and how they affect you. Our DIAmond Sessions will bring together innovators from industry, academia, and government agencies to discuss key concepts, and have a conversation on today’s priorities.
Tuesday, June 28
Join senior leadership from international regulatory authorities (EMA, FDA, PMDA) to hear the latest on multi- and bilateral initiatives that avoid duplication and increase mutual reliance, as well as a panel discussion with leaders from the International Coalition of Medicines Regulatory Authorities (ICMRA).
Tuesday, June 28
A diverse panel will discuss reframing the challenges of cultural change to achieve the best outcomes for patients in the health care process.
Tuesday, June 28
This forum will bring together a diverse panel representing some of the industry’s most influential and powerful organizations for a candid and innovative conversation about what is needed to shake up the current ecosystem and truly transform patient health.
Wednesday, June 29
This dynamic forward-focused session will bring together industry, technology innovators, academia, and government agencies to paint a colorful picture of how they will drive advances in health care founded on big data platforms.
Wednesday, June 29
This session will discuss the benefits and challenges of outcomes-based health care, as well as the remaining barriers to implementation.
Wednesday, June 29
Hear perspectives from multiple stakeholders to better understand the challenges and implications brought by this new focus towards value, and uncover ideas of collaboration to realize smarter health care spending.
Thursday, June 30
Leadership from the EMA and FDA will explore topics covered by the EMA/FDA confidentiality arrangements and discuss how both Agencies contribute to the global development and supervision of medicines.
Thursday, June 30
Unique viewpoints will be presented to serve as the basis for a moderated discussion that analyzes the current process for protocol development, while suggesting approaches to more fully incorporate the patient voice into protocol design and implementation.
